| Product Name | MF | CAS | Details |
|---|
| 1-acetyl-2,3,5-tribenzoyl-indole-D-ribofuranosyl clonerabine intermediate | Details |
| Sivires sodium tetrahydrate | Details |
| (5-acetyloxy-3,4-dibenzoyloxy-oxolan-2-yl)methyl benzoate | C28H24O9 | 70832-64-3 | Details |
| N-[2-[[[4-(2,2-Dimethyl-1-oxopropoxy)phenyl]sulfonyl]amino]benzoyl]-(S)-glycine monosodium salt | C20H21N2NaO7S | 150374-95-1 | Details |
| Olmesartan intermediate impurity IV | C13H22N2O3 | 1092980-84-1 | Details |
| (alphaR)-alpha-[[[2-(4-Nitrophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride | C16H18N2O3 | 521284-21-9 | Details |
| Olmesartan medoxomil impurity V | C45H42N6O2 | 157356-74-6 | Details |
| (3as,4R,5S,6ar)-(+)-hexahydro-5-hydroxy-4-hoch2-2 | C8H12O4 | 76704-05-7 | Details |
| Doripenem hydrate | C15H26N4O7S2 | 364622-82-2 | Details |
| 2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one | C30H35N5O3 | 184177-83-1 | Details |
| Trityl olmesartan impurity II | C19H15* | Details |
| Doripenem | C15H24N4O6S2 | 148016-81-3 | Details |
| (3aR,6aS)-3,3a,6,6a-tetrahydro-2H-cyclopenta[b]furan-2-one | C7H8O2 | 26054-46-6 | Details |
| (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester | C21H21F2N3O4S | 149809-43-8 | Details |
| 8-bromo-7-but-2-yn-1-yl-3-methyl-3,7-dihydro-1H-purine-2,6-dione | C10H9BrN4O2 | 666816-98-4 | Details |
| Olmesartan ethyl este | Details |
| (-)-Corey Lactone Benzoate | C15H16O5 | 39746-00-4 | Details |
| (R)-(-)-3-(Carbamoymethyl)-5-methylhexanoic acid | C9H17NO3 | 181289-33-8 | Details |
| 1,3,5-tribenzoyl-indole-D-ribofuranosyl clonerabine intermediate | Details |
| 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-carboxylic acid(5-methyl-2-oxo-1,3-dioxol-4-yl)methylester | C29H28N6O5 | 879562-26-2 | Details |
| Olmesartan medoxomil impurity II | C30H32N6O6 | 896419-17-3 | Details |
| 5-(4'-Methylbiphenyl-2-yl)-1-trityl-1H-tetrazole | C33H26N4 | 124750-53-4 | Details |
| 3-Carbamoymethyl-5-methylhexanoic acid | C9H17NO3 | 181289-15-6 | Details |
| 3-Methyl-8-bromoxanthine | C6H5BrN4O2 | 93703-24-3 | Details |
| Olmesartan intermediate impurity II | C11H16N2O3 | 144690-07-3 | Details |
| Trityl olmesartan impurity III | C19H15* | Details |
| 4-(chloromethyl)-5-methyl-1,3-dioxol-2-one | C5H5ClO3 | 80841-78-7 | Details |
| Benzonitrile, 2-[(6-chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]- | C13H10ClN3O2 | 865758-96-9 | Details |
| Olmesartan | C30H32N6O6 | 144689-78-1 | Details |
| Lise phosphate | Details |
| Faropene sodium dihydrate | Details |
| (R)-3-(Boc-Amino)piperidine | C10H20N2O2 | 309956-78-3 | Details |
| [1,1'-Biphenyl]-4-carboxylic acid,hexahydro-2-oxo-4-(3-oxodecyl)-2H-cyclopenta[b]furan-5-yl ester,[3aR-(3a,4,5,6a)]- | C30H36O5 | 120373-45-7 | Details |
| Olmesartan intermediate impurity VI | C12H18N2O2 | 157356-73-5 | Details |
| 2(1H)-Pentalenone, 5-(benzoyloxy)hexahydro-4-(hydroxymethyl)-, [3aS-(3a,4,5,6a)]- | C16H18O4 | 74842-93-6 | Details |
| Quinazoline, 2-(chloromethyl)-4-methyl- | C10H9ClN2 | 109113-72-6 | Details |
| Olmesartan intermediate impurity I | C13H22N2O3 | 172875-53-5 | Details |
| 1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine | C20H17BrN6O2 | 853029-57-9 | Details |
| 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetraz ol-5-yl][1,1'-biphenyl]-4-yl]methyl]-, ethyl ester | C45H44N6O3 | 144690-33-5 | Details |
| (R)-N-(4-nitrophenethyl)-2-hydroxy-2-phenylacetamide | C16H16N2O4 | 521284-19-5 | Details |
| Olmesartan medoxomil impurity III | Details |
| 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride | C8H18ClN3 | 25952-53-8 | Details |
| [2(S)-cis]-Octahydro-gamma-oxo-alpha-(phenylmethyl)-2H-isoindole-2-butanoic acid | C19H25NO3 | 145375-43-5 | Details |
| 1,3-Dioxol-2-one, 4-(hydroxymethyl)-5-methyl- | C5H6O4 | 91526-18-0 | Details |
| (S)-N-[[3-[3-Fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]amine | C14H18FN3O3 | 168828-90-8 | Details |
| [1,1'-Biphenyl]-4-carboxylic acid,(3aR,4R,5R,6aS)-hexahydro-4-[(1E,3S)-3-hydroxy-1-octen-1-yl]-2-oxo-2H-cyclopenta[b]furan-5-yl ester | C28H32O5 | 51014-26-7 | Details |
| Olmesartan medoxomil impurity IV | C48H50N12O5 | 1040250-19-8 | Details |
| Trityl olmesartan acid | C43H40N6O3 | 761404-85-7 | Details |
| Trityl olmesartan impurity I | C19H15* | Details |
| Mitiglinide calcium | (C19H24NO3)2.Ca | 145525-41-3 | Details |
| 6-[1-[(tert-Butyldimethylsilyl)oxy]ethyl]-7-oxo-3-(tetrahydro-3-furanyl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 2-propenyl ester | C21H33NO5SSi | 120705-71-7 | Details |
| 2-deoxy-2-fluoro-tribenzoyl-hydrazide-D-apolofuranose cloramide | Details |
| Mitiglinide dihydrate | Details |
| Siviresta tetrahydrate | Details |
| Faropenem dibasic hemihydrate | Details |
| Sodium selenate | Na2O4Se | Details |
| Product Total： Product Page： | ||||
| 1 2 | ||||